Best Price Pembrolizumab: Unmatched Deals & Details | Jamui| Bihar| India
Drug Category
Immunotherapy
Drug name
Pembrolizumab
Complete Drug Name
Pembrolizumab Injection
Mode of Delivery
Injection
Brand
Brand name: Keytruda Manufacturer: Merck & Co., Inc.
Dosage/Dose
Pembrolizumab Dose: 200mg via IV infusion, administered Q3W
Types of Cancer & Indication
Pembrolizumab is a sanctioned treatment for various malignancies, such as melanoma, non-small cell pulmonary carcinoma, head and neck squamous cell cancer, traditional Hodgkin's lymphoma, urothelial carcinoma, gastric and esophageal cancers, and neoplasms exhibiting microsatellite instability or compromised mismatch repair. This medication amplifies the immune response in targeting and eliminating tumor growth.
Mechanism of Action
Pembrolizumab, an innovative immunotherapy approach, enhances the patient's immune capacity to identify and eradicate malignant cells. It counters cancer by obstructing the abuse of the PD-1 protein, which assists in immune evasion, ultimately empowering the immune system. Displaying astonishing adaptability, pembrolizumab effectively combats diverse cancer forms, heralding a novel phase in tailor-made cancer treatment solutions.
Mechanism of Resistance
Resistance to Pembrolizumab injection occurs when cancer cells alter their architecture, thwarting immune checkpoint blocking and impairing T-cell engagement. This leads to diminished cancer antigen exposure and amplified suppressive factors, consequently diminishing pembrolizumab's potency and undermining its combat effectiveness against malignant proliferation.
Side Effects
Administering the Pembrolizumab injection might lead to a range of unfavorable effects, including persistent exhaustion, incessant coughs, nausea sensations, and irritated skin. In particular cases, the medication can induce critical outcomes such as autoimmune attacks on healthy organs, inflamed lungs, liver-related complications, or significant infusion-related problems. Thorough surveillance is crucial for prompt identification and intervention for these potential issues.
Combination Therapy
Pembrolizumab, a versatile cancer treatment, can be paired with various medications based on the particular cancer classification. Non-squamous non-small cell lung cancer (NSCLC) often benefits from combining pembrolizumab with pemetrexed and platinum-based chemotherapy drugs like cisplatin or carboplatin. Additionally, the FDA has sanctioned the simultaneous administration of pembrolizumab and axitinib to tackle advanced renal cell carcinoma (RCC). Seeking guidance from a healthcare specialist is crucial for tailoring individualized treatment plans.
Final Cost
Pembrolizumab Injection avg price: ₹71,000 (India). The above price is specific for Jamui, Bihar, India